FIELD: medicine.
SUBSTANCE: invention relates to a solid dosage form of sedative and hypnotic effect. Said dosage form is a tablet or capsule, which contains hydroxyzine in amount of 3.33 to 4.5 wt%, ethyl ether of α-bromo-isovaleric acid in amount of 5.47 to 7 wt%, peppermint oil or mixture thereof with hop oil in amount from 0.39 to 0.48 wt%, β-cyclodextrin in amount of 37-50 wt% and additives, including combined water.
EFFECT: invention is characterised by high sedative properties and hypnotic efficiency compared to existing analogues, which provides long sleep duration and faster onset thereof.
3 cl, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SOLID DRUG FORM OF MEDICATION WITH SEDATIVE AND ANTISPASMODIC EFFECT | 2013 |
|
RU2570374C2 |
| MEDICINE OF SEDATIVE AND ANTISPASMODIC EFFECT AND METHOD OF PREPARATION (VERSIONS) | 2005 |
|
RU2349334C2 |
| SEDATIVE AND SPASMOLITHIC MEANS AND METHOD FOR ITS PRODUCTION | 2015 |
|
RU2633064C2 |
| SEDATIVE AND MUSCLE RELAXANT ACTION DRUG | 2019 |
|
RU2719376C1 |
| SEDATIVE MEDICINAL PRODUCT IN THE FORM OF TABLETS | 2021 |
|
RU2770037C1 |
| METHOD OF OBTAINING A SOLID FORM OF THE DRUG SEDATIVE AND ANTISPASMODIC ACTION | 2015 |
|
RU2578432C9 |
| COMPOSITION AND METHOD OF PRODUCING MEDICINE | 2017 |
|
RU2675627C1 |
| PHARMACEUTICAL COMPOSITION OF SEDATIVE AND ANXIOLYTIC ACTION | 2020 |
|
RU2737701C1 |
| PHARMACEUTICAL COMPOSITION OF MEDICINAL AGENT OF SEDATIVE AND SPASMOLYTIC ACTION IN FORM OF SOFT GELATINE CAPSULES (VERSIONS) | 2013 |
|
RU2580290C2 |
| COMBINED HYPNOTIC AGENT IN THE FORM OF TABLETS | 2021 |
|
RU2769988C1 |
